XML 14 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2023
Cash Flows from Operating Activities          
Net increase (decrease) in net assets resulting from operations     $ (2,140,324) $ 1,170,222  
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:          
Origination and purchase of investments     (44,625,747) (38,535,317)  
Payment in-kind interest and dividends     (1,906,376) (1,101,142)  
Sales and repayments of investments $ 26,658,550 $ 14,917,260 68,788,139 46,998,760  
Net realized (gain) loss on investments 6,271,968 26,890,095 12,143,007 26,890,095  
Net change in unrealized appreciation/depreciation on investments (6,605,346) (23,237,794) (4,720,695) (20,827,357)  
Amortization of discount/premium on investments     (1,770,280) (1,056,482)  
Amortization of deferred debt issuance costs     423,885 520,000  
Amortization of original issue discount     53,333 53,333  
Net (increase) decrease in operating assets:          
Interest receivable     737,155 113,645  
Payment-in-kind interest receivable     (13,078) (46,836)  
Receivable for investments sold     (1,972,100) 51,238  
Principal receivable     45,889 0  
Due from affiliate     (175,916) 0  
Long-term receivable     (618,772) 0  
Escrow receivable     (95,190) 0  
Other receivables     1,050 (6,365)  
Prepaid expenses and other assets     (242,482) (100,487)  
Net increase (decrease) in operating liabilities:          
Payable for investments purchased     1,692,236 174,412  
Interest payable     679,188 1,384,062  
Directors fees payable     (15,755) (7,150)  
Accrued expenses and other liabilities     270,922 289,065  
Base management fees payable     (51,890) (100,736)  
Income-based incentive fees payable     (447,147) (148,232)  
Net cash (used in) provided by operating activities     26,039,052 15,714,728  
Cash Flows from Financing Activities:          
Payment for deferred financing costs     (1,010,788) 0  
Distributions to stockholders     (6,889,971) (8,610,939)  
Proceeds from borrowing on revolving financing facility     32,100,000 42,900,000  
Repayments of borrowing on revolving financing facility     (46,500,000) (45,000,000)  
Net cash (used in) provided by financing activities     (22,300,759) (10,710,939)  
Net change in cash     3,738,293 5,003,789  
Cash and restricted cash at beginning of year [1]     9,151,216 9,155,077 $ 9,155,077
Cash and restricted cash at end of period $ 12,889,509 [2] $ 14,158,866 [2] 12,889,509 [2] 14,158,866 [2] $ 9,151,216 [1]
Supplemental and non-cash financing cash flow information:          
Cash paid for interest     5,982,608 4,735,021  
Cash paid for taxes     267,150 294,330  
Issuance of shares pursuant to Dividend Reinvestment Plan     18,712 21,749  
Non-cash purchase of investments     (31,302,254) (8,043,963)  
Non-cash sale of investments     $ 31,302,254 $ 8,043,963  
[1] Represents $1,093,758 and $2,550,021 of unrestricted cash as of June 30, 2023 and June 30, 2022, respectively, and $8,057,458 and $6,605,056 of restricted cash for the same periods .
[2] Represents $2,728,347 and $2,902,376 of unrestricted cash as of March 31, 2024 and March 31, 2023, respectively, and $10,161,162 and $11,256,490 of restricted cash for the same periods .